Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,803 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02755844 | Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients(ENDOLA) | completed | Phase 1 / Phase 2 | 35 | Hospices Civils de LyonOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06010160 | Game Changers for Cervical Cancer Prevention(GC-CCP) | completed | N/A | 936 | RANDOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT03570827 | Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy | completed | Phase 2 | 53 | Mayo ClinicOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03934840 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | completed | Phase 2 | 61 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03503643 | Hemi-Gland Cryoablation for Prostate Cancer at UCLA | completed | — | 354 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04687969 | Multimodal Machine Learning Characterization of Solid Tumors | completed | — | 50 | Ciprian Catana, MD, PhDOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT05044975 | Improving Sleep in Gynecologic Cancer Survivors | completed | N/A | 78 | University of ArizonaOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06102252 | Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma | completed | N/A | 60 | Sohag UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT01823562 | Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery | completed | Phase 1 | 60 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT03430700 | Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer(PROMPT) | completed | Phase 2 | 20 | University College, LondonOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT04008095 | Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer(COLTEP) | completed | — | 40 | University Hospital, BrestOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT02397317 | Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring(SPARK) | completed | N/A | 49 | University of SydneyOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT05146297 | Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials(DISRUPT) | completed | N/A | 585 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT00911118 | Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer | completed | Phase 1 | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT06298305 | Artificial Intelligence & Prostate Cancer(QUANTIB) | completed | — | 200 | IRCCS San RaffaeleOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT03910660 | A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. | completed | Phase 1 / Phase 2 | 98 | BioXcel Therapeutics IncINDUSTRY | 2 | May 15, 2026 | clinicaltrials |
| NCT04019964 | Nivolumab in Biochemically Recurrent dMMR Prostate Cancer | completed | Phase 2 | 8 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT06255041 | Detection of Cancer in Breath Samples by Trained Detection Dogs | completed | — | 1,386 | SpotitEarlyINDUSTRY | 1 | May 15, 2026 | clinicaltrials |
| NCT06807398 | Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate Cancer(RF-2018-123683) | completed | — | 367 | Francesco MontorsiOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07485257 | Molecular Profiling of MRI-PSMA PET Discordance in Prostate Cancer(MP-PET-MRI) | completed | — | 30 | IRCCS San RaffaeleOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07491406 | A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance(PRS-AS) | completed | — | 185 | IRCCS San RaffaeleOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT02386137 | Factors Influencing Volumetric MR-HIFU Ablation of Uterine Fibroids(PERAGUS) | completed | N/A | 40 | University Hospital, BordeauxOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT03604757 | 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks(UROPET) | completed | Phase 2 | 22 | University Hospital, BordeauxOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT03644303 | Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.(TRAP) | completed | N/A | 86 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT04214210 | The DIALOGUE Study: Swiss-Korean Billateral Collaboration(DIALOGUE) | completed | N/A | 128 | University of BaselOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT04295577 | Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR(MONITOR-UK) | completed | — | 388 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT02761889 | Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer | completed | N/A | 444 | Fundacao ChampalimaudOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT04731844 | Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer | completed | Phase 2 | 30 | University of RochesterOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT00959647 | A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study | completed | Phase 2 | 19 | Genentech, Inc.INDUSTRY | 1 | May 8, 2026 | clinicaltrials |
| NCT05114746 | Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan | completed | Phase 2 | 94 | Novartis PharmaceuticalsINDUSTRY | 1 | May 8, 2026 | clinicaltrials |
| NCT07462403 | A Prolonged Nightly Fasting for Men on ADT for PCa | completed | N/A | 40 | Thomas Jefferson UniversityOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT03123978 | Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 6 | University of California, DavisOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04565457 | A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality | completed | N/A | 43 | University of Colorado, DenverOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04726319 | Family History App in Personalized Medicine(FHAMe) | completed | N/A | 627 | University of TorontoOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06575361 | Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis | completed | N/A | 365 | Peking University First HospitalOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07568444 | Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3) | completed | Phase 2 | 120 | University of Southern CaliforniaOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT05005728 | XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 72 | Xencor, Inc.INDUSTRY | 1 | May 5, 2026 | clinicaltrials |
| NCT05409872 | Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids(DEFIB) | completed | N/A | 108 | Universita di VeronaOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07567573 | Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery(retroESGO ov1) | completed | — | 11,383 | European Society of Gynaecological OncologyOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03797326 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | completed | Phase 2 | 611 | Merck Sharp & Dohme LLCINDUSTRY | 17 | May 4, 2026 | clinicaltrials |
| NCT04739527 | Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment(ALISON) | completed | Phase 1 | 17 | University Medical Center GroningenOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07561502 | Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue(PERI III) | completed | N/A | 32 | Francis Medical Inc.INDUSTRY | 1 | May 1, 2026 | clinicaltrials |
| NCT06661044 | Understanding the Benefits of Dietary Fibre Supplementation in Patients With Prostate Cancer(EVENTIDE) | completed | — | 6 | University of AberdeenOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT02649855 | Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer | completed | Phase 2 | 74 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2026 | clinicaltrials |
| NCT03218826 | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 23 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2026 | clinicaltrials |
| NCT04558398 | Impact of Exercise on Mitochondria in Cancer Patients.(ICCE-Mito) | completed | N/A | 15 | University of NottinghamOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07547267 | The Effect of Vaginal Dilator Use | completed | N/A | 80 | Istanbul Aydın UniversityOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT04185389 | Long-Term Follow-Up of HPV FOCAL Participants(HPV FOCAL) | completed | — | 1,710 | University of British ColumbiaOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT05133440 | A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones | completed | Phase 2 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT05156268 | A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma | completed | Phase 2 | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 27, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 27, 2026source: clinicaltrials